BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The unregulated kinase activity of the BCR‐ABL1 oncoprotein mediates autophosphorylation and activation of multiple downstream signaling pathways and results in the uncontrolled proliferation and reduced apoptosis of CML cells 1.